RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.040
0.00 (0.00%)
At close: Nov 5, 2024, 4:00 PM
1.000
-0.040 (-3.85%)
After-hours: Nov 5, 2024, 4:31 PM EST
RenovoRx Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for RenovoRx stock have an average target of 6.13, with a low estimate of 4.00 and a high estimate of 8.25. The average target predicts an increase of 489.42% from the current stock price of 1.04.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 12, 2024.
Analyst Ratings
The average analyst rating for RenovoRx stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8 → $8.25 | Strong Buy | Maintains | $8 → $8.25 | +693.27% | Sep 12, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +669.23% | Jun 17, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +284.62% | Feb 2, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +1,150.00% | Aug 18, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.41
from -0.99
EPS Next Year
-0.42
from -0.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 25.6M | ||
| Avg | n/a | n/a | 12.4M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.41 | -0.41 | -0.04 |
| Avg | -0.41 | -0.42 | -0.15 |
| Low | -0.40 | -0.44 | -0.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.